<em>Dracocephalum moldavica L.</em> extract alleviates experimental colitis in rats by modulating gut microbiome and inflammatory pathways

Gang,Suhe; Gang,Suhe; Bai,Wenhui; Bai,Wenhui; Yu,Hui; Yu,Hui; A,Gula; A,Gula; Wang,Zhanli; Wang,Zhanli

doi:10.3892/mmr.2023.13115

Dracocephalum moldavica L. extract alleviates experimental colitis in rats by modulating gut microbiome and inflammatory pathways

Authors:
- Suhe Gang
- Wenhui Bai
- Hui Yu
- Gula A
- Zhanli Wang
View Affiliations

Affiliations: Mongolian Medicine School, Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region 010110, P.R. China, Inner Mongolia Key Laboratory of Disease‑Related Biomarkers, The Second Affiliated Hospital, Baotou Medical College, Baotou, Inner Mongolia Autonomous Region 014030, P.R. China
Published online on: October 17, 2023 https://doi.org/10.3892/mmr.2023.13115
Article Number: 228

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Several studies have revealed that an imbalance of the intestinal microbiota is involved in intestinal inflammation associated with ulcerative colitis (UC). Therefore, regulating the homeostasis of gut microbiota is critical for treating UC. Dracocephalum moldavica L. (DML) extract, a common traditional Chinese medicine, has been demonstrated to possess numerous pharmacological effects, such as antioxidative, anti‑inflammatory, and antibacterial properties. The aim of the present study was to evaluate the beneficial effects of DML extract and the probable mechanism of action in a dextran sulfate sodium‑induced chronic colitis model. It was found that DML extract ameliorated UC by improving disease activity index, weight loss, colon length, and histological scoring. DML extract administration also enhanced the count of Lactobacillus and reduced the count of Romboutsia. Furthermore, the results of network pharmacology analysis revealed that the active ingredients (including luteolin, rosmarinic acid, oleanolic acid, ursolic acid, apigenin, acacetin, kaempferol, and isorhamnetin) in the DML extract were closely associated with anti‑inflammatory activity via various signaling pathways, including the NF‑κB, IL‑17, TNF, and Toll‑like receptor (TLR) signaling pathways. Western blot analysis further indicated that DML extract downregulated the expression of members of the TLR4/NF‑κB signaling pathway, which was associated with colitis. Thus, it was hypothesized that DML extract exerted its anti‑colitis effects by modulating the gut microbiota and inflammatory pathways.

View References

1	Yuan X, Chen B, Duan Z, Xia Z, Ding Y, Chen T, Liu H, Wang B, Yang B, Wang X, et al: Depression and anxiety in patients with active ulcerative colitis: Crosstalk of gut microbiota, metabolomics and proteomics. Gut Microbes. 13:19877792021. View Article : Google Scholar : PubMed/NCBI
2	Gomaa EZ: Human gut microbiota/microbiome in health and diseases: A review. Antonie Van Leeuwenhoek. 113:2019–2040. 2020. View Article : Google Scholar : PubMed/NCBI
3	Weiss GA and Hennet T: Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci. 74:2959–2977. 2017. View Article : Google Scholar : PubMed/NCBI
4	Popov J, Caputi V, Nandeesha N, Rodriguez DA and Pai N: Microbiota-immune interactions in ulcerative colitis and colitis associated cancer and emerging microbiota-based therapies. Int J Mol Sci. 22:113652021. View Article : Google Scholar : PubMed/NCBI
5	Richard ML, Liguori G, Lamas B, Brandi G, da Costa G, Hoffmann TW, Pierluigi Di Simone M, Calabrese C, Poggioli G, Langella P, et al: Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes. 9:131–142. 2018. View Article : Google Scholar : PubMed/NCBI
6	Ramos GP and Papadakis KA: Mechanisms of disease: Inflammatory bowel diseases. Mayo Clin Proc. 94:155–165. 2019. View Article : Google Scholar : PubMed/NCBI
7	Adak A and Khan MR: An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 76:473–493. 2019. View Article : Google Scholar : PubMed/NCBI
8	Gong X, Li X, Bo A, Shi RY, Li QY, Lei LJ, Zhang L and Li MH: The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review. Pharmacol Res. 157:1048242020. View Article : Google Scholar : PubMed/NCBI
9	Chen YZ, Yuan MY, Chen YL, Zhang X, Xu XT, Liu SL, Zou X, Tao JL, Qiang YH, Wu J and Sun QM: The gut microbiota and traditional Chinese medicine: A new clinical frontier on cancer. Curr Drug Targets. 22:1222–1231. 2021. View Article : Google Scholar : PubMed/NCBI
10	Jin M, Yu H, Jin X, Yan L, Wang J and Wang Z: Dracocephalum moldavica L. extracts protect H9c2 cardiomyocytes against H₂O₂-induced apoptosis and oxidative stress. Biomed Res Int. 2020:83793582020. View Article : Google Scholar : PubMed/NCBI
11	Yu H, Liu M, Liu Y, Qin L, Jin M and Wang Z: Antimicrobial activity and mechanism of action of Dracocephalum moldavica L. extracts against clinical isolates of Staphylococcus aureus. Front Microbiol. 10:12492019. View Article : Google Scholar : PubMed/NCBI
12	Nie L, Li R, Huang J, Wang L, Ma M, Huang C, Wu T, Yan R and Hu X: Abietane diterpenoids from Dracocephalum moldavica L. and their anti-inflammatory activities in vitro. Phytochemistry. 184:1126802021. View Article : Google Scholar : PubMed/NCBI
13	Fattahi A, Shakeri A, Tayarani-Najaran Z, Kharbach M, Segers K, Heyden YV, Taghizadeh SF, Rahmani H and Asili J: UPLC-PDA-ESI-QTOF-MS/MS and GC-MS analysis of Iranian Dracocephalum moldavica L. Food Sci Nutr. 9:4278–4286. 2021. View Article : Google Scholar : PubMed/NCBI
14	Zhang J, Dou W, Zhang E, Sun A, Ding L, Wei X, Chou G, Mani S and Wang Z: Paeoniflorin abrogates DSS-induced colitis via a TLR4-dependent pathway. Am J Physiol Gastrointest Liver Physiol. 306:G27–G36. 2014. View Article : Google Scholar : PubMed/NCBI
15	Yu H, Yu H, Si L, Meng H, Chen W, Wang Z and Gula A: Influence of warm acupuncture on gut microbiota and metabolites in rats with insomnia induced by PCPA. PLoS One. 17:e02678432022. View Article : Google Scholar : PubMed/NCBI
16	Zhang L, Han L, Wang X, Wei Y, Zheng J, Zhao L and Tong X: Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking. Biosci Rep. 41:BSR202035202021. View Article : Google Scholar : PubMed/NCBI
17	Kanehisa M and Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30. 2000. View Article : Google Scholar : PubMed/NCBI
18	Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
19	Huang da W, Sherman BT and Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
20	Chassaing B, Aitken JD, Malleshappa M and Vijay-Kumar M: Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 104:15.25.1–15.25.14. 2014. View Article : Google Scholar : PubMed/NCBI
21	Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S and Neurath MF: Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 12:1295–1309. 2017. View Article : Google Scholar : PubMed/NCBI
22	Fujino Y, Kanmura S, Morinaga Y, Kojima I, Maeda N, Tanaka A, Maeda H, Kumagai K, Sasaki F, Tanoue S and Ido A: Hepatocyte growth factor ameliorates dextran sodium sulfate-induced colitis in a mouse model by altering the phenotype of intestinal macrophages. Mol Med Rep. 27:702023. View Article : Google Scholar : PubMed/NCBI
23	Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M and Li X: Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis. 15:341–352. 2009. View Article : Google Scholar : PubMed/NCBI
24	Yu D, Zhao Y, Wang H, Kong D, Jin W, Hu Y, Qin Y, Zhang B, Li X, Hao J, et al: IL-1β pre-stimulation enhances the therapeutic effects of endometrial regenerative cells on experimental colitis. Stem Cell Res Ther. 12:3242021. View Article : Google Scholar : PubMed/NCBI
25	Yang C, Du Y, Ren D, Yang X and Zhao Y: Gut microbiota-dependent catabolites of tryptophan play a predominant role in the protective effects of turmeric polysaccharides against DSS-induced ulcerative colitis. Food Funct. 12:9793–9807. 2021. View Article : Google Scholar : PubMed/NCBI
26	Fan Q, Guan X, Hou Y, Liu Y, Wei W, Cai X, Zhang Y, Wang G, Zheng X and Hao H: Paeoniflorin modulates gut microbial production of indole-3-lactate and epithelial autophagy to alleviate colitis in mice. Phytomedicine. 79:1533452020. View Article : Google Scholar : PubMed/NCBI
27	Hasannejad-Bibalan M, Mojtahedi A, Eshaghi M, Rohani M, Pourshafie MR and Talebi M: The effect of selected Lactobacillus strains on dextran sulfate sodium-induced mouse colitis model. Acta Microbiol Immunol Hung. 67:138–142. 2020. View Article : Google Scholar : PubMed/NCBI
28	Wang HG, Zhang MN, Wen X, He L, Zhang MH, Zhang JL and Yang XZ: Cepharanthine ameliorates dextran sulphate sodium-induced colitis through modulating gut microbiota. Microb Biotechnol. 15:2208–2222. 2022. View Article : Google Scholar : PubMed/NCBI
29	Adams SM, Close ED and Shreenath AP: Ulcerative colitis: Rapid evidence review. Am Fam Physician. 105:406–411. 2022.PubMed/NCBI
30	Yılmaz İ, Dolar ME and Özpınar H: Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial. Turk J Gastroenterol. 30:242–253. 2019. View Article : Google Scholar : PubMed/NCBI
31	Pang B, Jin H, Liao N, Li J, Jiang C, Shao D and Shi J: Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. Food Funct. 12:5171–5186. 2021. View Article : Google Scholar : PubMed/NCBI
32	Yang B, Li M, Wang S, Ross RP, Stanton C, Zhao J, Zhang H and Chen W: Lactobacillus ruminis alleviates DSS-induced colitis by inflammatory cytokines and gut microbiota modulation. Foods. 10:13492021. View Article : Google Scholar : PubMed/NCBI
33	Wang T, Zheng J, Dong S, Ismael M, Shan Y, Wang X and Lü X: Lacticaseibacillus rhamnosus LS8 ameliorates azoxymethane/dextran sulfate sodium-induced colitis-associated tumorigenesis in mice via regulating gut microbiota and inhibiting inflammation. Probiotics Antimicrob Proteins. 14:947–959. 2022. View Article : Google Scholar : PubMed/NCBI
34	Duan L, Cheng S, Li L, Liu Y, Wang D and Liu G: Natural anti-inflammatory compounds as drug candidates for inflammatory bowel disease. Front Pharmacol. 12:6844862021. View Article : Google Scholar : PubMed/NCBI
35	Sen A: Prophylactic and therapeutic roles of oleanolic acid and its derivatives in several diseases. World J Clin Cases. 8:1767–1792. 2020. View Article : Google Scholar : PubMed/NCBI
36	Sheng Q, Li F, Chen G, Li J, Li J, Wang Y, Lu Y, Li Q, Li M and Chai K: Ursolic acid regulates intestinal microbiota and inflammatory cell infiltration to prevent ulcerative colitis. J Immunol Res. 2021:66793162021. View Article : Google Scholar : PubMed/NCBI
37	Lv F, Zhang Y, Peng Q, Zhao X, Hu D, Wen J, Liu K, Li R, Wang K and Sun J: Apigenin-Mn(II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice. Front Chem. 10:9699622022. View Article : Google Scholar : PubMed/NCBI
38	Ren J, Yue B, Wang H, Zhang B, Luo X, Yu Z, Zhang J, Ren Y, Mani S, Wang Z and Dou W: Acacetin ameliorates experimental colitis in mkice via inhibiting macrophage inflammatory response and regulating the composition of gut microbiota. Front Physiol. 11:5772372021. View Article : Google Scholar : PubMed/NCBI
39	Dou W, Zhang J, Li H, Kortagere S, Sun K, Ding L, Ren G, Wang Z and Mani S: Plant flavonol isorhamnetin attenuates chemically induced inflammatory bowel disease via a PXR-dependent pathway. J Nutr Biochem. 25:923–933. 2014. View Article : Google Scholar : PubMed/NCBI
40	Ren J, Lu Y, Qian Y, Chen B, Wu T and Ji G: Recent progress regarding kaempferol for the treatment of various diseases. Exp Ther Med. 18:2759–2776. 2019.PubMed/NCBI
41	Pastille E, Faßnacht T, Adamczyk A, Ngo Thi Phuong N, Buer J and Westendorf AM: Inhibition of TLR4 signaling impedes tumor growth in colitis-associated colon cancer. Front Immunol. 12:6697472021. View Article : Google Scholar : PubMed/NCBI
42	Yang QY, Ma LL, Zhang C, Lin JZ, Han L, He YN and Xie CG: Exploring the mechanism of indigo naturalis in the treatment of ulcerative colitis based on TLR4/MyD88/NF-κB signaling pathway and gut microbiota. Front Pharmacol. 12:6744162021. View Article : Google Scholar : PubMed/NCBI
43	Shen W, Anwaier G, Cao Y, Lian G, Chen C, Liu S, Tuerdi N and Qi R: Atheroprotective mechanisms of tilianin by inhibiting inflammation through down-regulating NF-κB pathway and foam cells formation. Front Physiol. 10:8252019. View Article : Google Scholar : PubMed/NCBI
44	Zhou Y, Zhang M, Zhao X and Feng J: Ammonia exposure induced intestinal inflammation injury mediated by intestinal microbiota in broiler chickens via TLR4/TNF-α signaling pathway. Ecotoxicol Environ Saf. 226:1128322021. View Article : Google Scholar : PubMed/NCBI